Genpact Q3 2026: ATS Growth 30% Drives Guidance Raise

What happened

Genpact reported strong Q3 2026 results with Advanced Technology Solutions net revenue surging 30% year-over-year, underscoring the success of its Agentic Operations pivot. The company raised its full-year 2026 guidance for gross margin and adjusted diluted earnings per share, reflecting improved operating leverage and a favorable revenue mix shift toward higher-value technology services. This performance aligns with the DeepValue master report's emphasis on the accelerating mix shift from Core Business Services to ATS, which is a key driver of potential margin expansion and rerating. While the headline numbers are impressive, investors should note that one quarter of rapid growth does not guarantee durability, as conversion of GenAI pilots to scaled production remains a critical variable. Nevertheless, the combination of strong ATS momentum, raised guidance, and a valuation still below large-cap peers supports a constructive view, though vigilance on pricing and execution is warranted.

Implication

Investors should see Genpact's Q3 as validation that its Agentic Operations strategy is gaining traction, with ATS revenue growth of 30% indicating strong demand for AI-led services. The raised guidance for gross margin and EPS suggests management is confident in ongoing margin accretion from the mix shift, which could compress the valuation gap versus larger IT services peers. However, the market may already be factoring in some of this optimism, so the real test will be whether ATS growth remains above 25% for several quarters and whether the company can sustain pricing power. Long-term holders with an eye on the transition from legacy BPO to higher-value technology work should continue to monitor bookings, headcount utilization, and cash conversion, as these are leading indicators of durability. Overall, the news tilts the risk-reward positively, but patience and selective entry points are advisable given the stock may have already partially rerated on the back of these results.

Thesis delta

The Q3 report provides concrete evidence that the Advanced Technology Solutions mix shift is accelerating, which strengthens the original buy thesis focused on higher-value revenue and margin expansion. While the stance remains BUY, the thesis delta is a slight increase in conviction, as the company's guidance raise validates management's execution. However, we maintain a watchful eye on sustainability and the conversion of AI pilots to production, as these remain the main risks to the thesis.